New York State Common Retirement Fund’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

New York State Common Retirement Fund’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-26,601	Closed	-$245K	–	3348
2017 Q1	$245K	Buy	26,601 +9,001	+51%	+$79K	﹤0.01%	2691
2016 Q4	$136K	Hold	17,600	–	–	﹤0.01%	2902
2016 Q3	$201K	Hold	17,600	–	–	﹤0.01%	2764
2016 Q2	$217K	Hold	17,600	–	–	﹤0.01%	2690
2016 Q1	$178K	Hold	17,600	–	–	﹤0.01%	2730
2015 Q4	$397K	Hold	17,600	–	–	﹤0.01%	2419
2015 Q3	$292K	Buy	17,600 +1,739	+11%	+$34.9K	﹤0.01%	2590
2015 Q2	$357K	Buy	+15,861	New	+$391K	﹤0.01%	2680

Other funds holding OMED

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's OMED Position: Q2 2017 in Review

New York State Common Retirement Fund sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2017, closing a stake of 26,601 shares — an estimated $245K sold.

New York State Common Retirement Fund first reported a position in OMED in Q2 2015 and held it in 8 quarters. The position peaked at $397K in Q4 2015. 68 funds tracked by Wall St. Rank hold OMED as of Q2 2017.

New York State Common Retirement Fund reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
New York State Common Retirement Fund sold 26,601 OncoMed Pharmaceuticals, Inc. shares in Q2 2017, an estimated $245K.
New York State Common Retirement Fund first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
New York State Common Retirement Fund's OncoMed Pharmaceuticals, Inc. position peaked at $397K in Q4 2015.
68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2017.

Based on New York State Common Retirement Fund's 13F filing for Q2 2017, filed 11 Aug 2017.